331 results
Page 5 of 17
424B5
wq027idzk2vsye5z
12 Nov 20
Prospectus supplement for primary offering
4:21pm
424B3
wv19l
9 Nov 20
Prospectus supplement
8:20am
8-K
EX-99.1
3vnuut6gf
5 Nov 20
Bristol Myers Squibb Reports Third Quarter 2020 Financial Results
8:10am
SC TO-T
EX-99
hf5juybicvv0cu
19 Oct 20
Third party tender offer statement
6:03am
SC TO-T
EX-99
wdqu774ps
19 Oct 20
Third party tender offer statement
6:03am
SC TO-C
EX-99.2
vau oxvms7p2hou3
5 Oct 20
Information about tender offer
5:13pm
SC TO-C
EX-99.3
uw9fsclbe0od
5 Oct 20
Information about tender offer
5:13pm
SC TO-C
EX-99.1
2r7w25 3o
5 Oct 20
Information about tender offer
5:13pm
8-K
EX-99.1
qrl8p
5 Oct 20
Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash
4:05pm
8-K
EX-99.1
brfpxp 5xu94pwasv
6 Aug 20
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
7:57am
8-K
EX-99.1
ri0 5fe0lvyuhknp91
16 Jul 20
Bristol Myers Squibb Announces Expiration and Final Results of Registered Exchange Offers
8:30am
8-K
EX-99.1
95t5chyg bmhlx2i5
16 Jun 20
Bristol Myers Squibb Announces Commencement of Registered Exchange Offers
8:39am
424B3
peiqmep
16 Jun 20
Prospectus supplement
8:01am
8-K
EX-99.1
dygzk
7 May 20
Bristol Myers Squibb Reports Strong First Quarter 2020 Financial Results
8:08am
DEFA14A
5awe684c
23 Apr 20
Additional proxy soliciting materials
8:59am
8-K
EX-99.1
7vvonzdecc10ymk j0y
14 Apr 20
Bristol Myers Squibb Announces Virtual 2020 Annual Meeting of Shareholders
4:36pm